News & Events
Last week, October
Thank you to everyone who stopped by our booth #190! It was great to connect with industry peers and discuss the latest developments in
Our team also delivered two presentations exploring how AI can accelerate drug discovery.
Gene-to-Drug Hit Discovery
By Chris Waller, PhD, Chief Strategist
Chris presented Quantori's approach to accelerating the journey from biological targets to promising drug candidates. Key highlights:
- Using agentic AI to connect scientific literature, biological data, and molecular modeling.
- Automating hit generation and prioritization while keeping scientists in control of critical decisions.
- Accelerating the discovery of novel, synthesizable compounds through configurable
AI-driven workflows.
Download presentation slides.
MLConfGen: Transforming Hit Discovery with Generative AI
Alexander Proutski, PhD, Senior Director, Data Science
The presentation explored how Quantori's MLConfGen speeds up molecular generation and reduces costs. Key highlights:
- Generating promising molecules directly, rather than screening millions of compounds.
- Reducing the number of compounds evaluated by 10–100 times, lowering computational costs.
- Enabling pocket-driven molecular design, fragment growth, and multi-objective optimization.
Download presentation slides or learn more about MLConfGen on our website.
Thank you to everyone who joined us at BioTechX Europe 2026! We look forward to continuing the conversations and exploring new opportunities to advance life sciences research together.